• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HPV 口咽癌效应 T 细胞中 CD137/Eomes 激活轴的假说。

Hypothesis of a CD137/Eomes activating axis for effector T cells in HPV oropharyngeal cancers.

机构信息

Department of Otolaryngology-Head & Neck Surgery, Foch Hospital, 40 rue Worth, 92 150, Suresnes, France.

School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en- Yvelines (Paris Saclay University), 2 Av. de la Source de la Bièvre, Montigny- le-Bretonneux, 78 180, France.

出版信息

Mol Med. 2024 Feb 14;30(1):26. doi: 10.1186/s10020-024-00796-w.

DOI:10.1186/s10020-024-00796-w
PMID:38355394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10868089/
Abstract

Chronic Human Papilloma Virus (HPV) infection is supplanting alcohol and tobacco intoxications as the leading cause of oropharyngeal cancer in developed countries. HPV-related squamous cell carcinomas of the oropharynx (HPV + OSC) present better survival and respond better to radiotherapy and chemotherapy. Regulatory T cells (T) are mainly described as immunosuppressive and protumoral in most solid cancers. However, T are paradoxically associated with a better prognosis in HPV + OSCs. The transcription factor FoxP3 is the basis for the identification of T. Among CD4 + FoxP3 + T cells, some have effector functions. A medical hypothesis is formulated here: the existence of a CD137 (4.1BB)-Eomesodermin (Eomes) activated pathway downstream of TCR-specific activation in a subpopulation of CD4 + FoxP3 + T cells may explain this effector function. Evidence suggest that this axis may exist either in CD4 + FoxP3 + T cells or CD8 + T cells. This pathway could lead T cells to strong antitumor cytotoxic activity in a tumor-specific manner. Furthermore, CD137 is one of the most expected targets for the development of agonist immunotherapies. The identification of CD137 + Eomes + FoxP3+/- T cells could be a key element in the selective activation of the most anti-tumor cells in the HPV + OSC microenvironment.

摘要

慢性人乳头瘤病毒(HPV)感染正在取代酒精和烟草中毒,成为发达国家口咽癌的主要病因。与 HPV 相关的口咽鳞状细胞癌(HPV+OSC)的生存率更高,对放疗和化疗的反应更好。调节性 T 细胞(T)在大多数实体瘤中主要被描述为免疫抑制和促肿瘤。然而,T 与 HPV+OSC 中的更好预后相关。转录因子 FoxP3 是鉴定 T 的基础。在 CD4+FoxP3+T 细胞中,一些具有效应功能。这里提出了一个医学假设:在 TCR 特异性激活的亚群中,下游存在 CD137(4.1BB)-Eomesodermin(Eomes)激活途径,可能解释了这种效应功能。有证据表明,该轴可能存在于 CD4+FoxP3+T 细胞或 CD8+T 细胞中。该途径可以使 T 细胞以肿瘤特异性方式产生强烈的抗肿瘤细胞毒性活性。此外,CD137 是开发激动剂免疫疗法最有希望的靶点之一。CD137+Eomes+FoxP3+/-T 细胞的鉴定可能是在 HPV+OSC 微环境中选择性激活最抗肿瘤细胞的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f431/10868089/b9caf904fca7/10020_2024_796_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f431/10868089/b9caf904fca7/10020_2024_796_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f431/10868089/b9caf904fca7/10020_2024_796_Fig1_HTML.jpg

相似文献

1
Hypothesis of a CD137/Eomes activating axis for effector T cells in HPV oropharyngeal cancers.HPV 口咽癌效应 T 细胞中 CD137/Eomes 激活轴的假说。
Mol Med. 2024 Feb 14;30(1):26. doi: 10.1186/s10020-024-00796-w.
2
CD137 Agonist Therapy Can Reprogram Regulatory T Cells into Cytotoxic CD4+ T Cells with Antitumor Activity.CD137激动剂疗法可将调节性T细胞重编程为具有抗肿瘤活性的细胞毒性CD4+T细胞。
J Immunol. 2016 Jan 1;196(1):484-92. doi: 10.4049/jimmunol.1403039. Epub 2015 Nov 25.
3
Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.Tbet 阳性调节性 T 细胞在存在持续肿瘤特异性 1 型 T 细胞应答的口咽癌中积累。
J Immunother Cancer. 2019 Jan 18;7(1):14. doi: 10.1186/s40425-019-0497-0.
4
An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.一种免疫治疗性 CD137 激动剂释放 CD4 T 细胞中 Eomesodermin 从 ThPOK 抑制中释放。
J Immunol. 2018 Feb 15;200(4):1513-1526. doi: 10.4049/jimmunol.1701039. Epub 2018 Jan 5.
5
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.FOXP3+ 调节性 T 细胞对局部晚期口咽鳞状细胞癌患者的预后价值。
PLoS One. 2022 Oct 6;17(10):e0274830. doi: 10.1371/journal.pone.0274830. eCollection 2022.
6
CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.CD8-αT 细胞浸润与 HPV 相关口咽癌患者的预后改善相关。
Int J Cancer. 2013 Jan 15;132(2):E26-36. doi: 10.1002/ijc.27776. Epub 2012 Sep 1.
7
Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer.浸润性淋巴细胞与人类乳头瘤病毒 16 型相关的口咽癌。
Laryngoscope. 2012 Jan;122(1):121-7. doi: 10.1002/lary.22133.
8
A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.口咽鳞状细胞癌中有益的肿瘤微环境的特征是T细胞频率高和IL-17(+)细胞频率低。
Cancer Immunol Immunother. 2016 Apr;65(4):393-403. doi: 10.1007/s00262-016-1805-x. Epub 2016 Feb 22.
9
Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.Eomesodermin在CD4+ T细胞中的表达限制外周Foxp3的诱导。
J Immunol. 2015 Nov 15;195(10):4742-52. doi: 10.4049/jimmunol.1501159. Epub 2015 Oct 9.
10
Exploring the link between human papilloma virus and oral and oropharyngeal cancers.探索人乳头瘤病毒与口腔癌和口咽癌之间的联系。
J Cancer Res Ther. 2014 Jul-Sep;10(3):492-8. doi: 10.4103/0973-1482.138213.

引用本文的文献

1
Targeted inhibition of Aurora kinase A promotes immune checkpoint inhibition efficacy in human papillomavirus-driven cancers.靶向抑制极光激酶A可提高人乳头瘤病毒驱动癌症中免疫检查点抑制的疗效。
J Immunother Cancer. 2025 Jan 7;13(1):e009316. doi: 10.1136/jitc-2024-009316.

本文引用的文献

1
Regulation of CD4 T Cell Responses by the Transcription Factor Eomesodermin.转录因子 Eomesodermin 对 CD4 T 细胞应答的调节。
Biomolecules. 2022 Oct 24;12(11):1549. doi: 10.3390/biom12111549.
2
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.FOXP3+ 调节性 T 细胞对局部晚期口咽鳞状细胞癌患者的预后价值。
PLoS One. 2022 Oct 6;17(10):e0274830. doi: 10.1371/journal.pone.0274830. eCollection 2022.
3
Phenotypic and Functional Studies of Human Treg Cell Subpopulations.
人类调节性 T 细胞亚群的表型和功能研究。
Methods Mol Biol. 2023;2559:153-169. doi: 10.1007/978-1-0716-2647-4_11.
4
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials.评估纳武利尤单抗联合或不联合伊匹单抗与安慰剂在 III 期随机对照试验中的 hyperprogression 与疾病自然进展的情况。
J Immunother Cancer. 2022 Apr;10(4). doi: 10.1136/jitc-2021-004273.
5
Remodeling of the tumor microenvironment via disrupting Blimp1 effector Treg activity augments response to anti-PD-1 blockade.通过破坏 Blimp1 效应性 Treg 活性重塑肿瘤微环境可增强对抗 PD-1 封锁的反应。
Mol Cancer. 2021 Nov 20;20(1):150. doi: 10.1186/s12943-021-01450-3.
6
Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.人乳头瘤病毒对口咽鳞状细胞癌肿瘤微环境的影响。
Int J Cancer. 2022 Feb 1;150(3):521-531. doi: 10.1002/ijc.33849. Epub 2021 Nov 3.
7
A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade.一种人源 CD137×PD-L1 双特异性抗体通过依赖于背景的 T 细胞共刺激和检查点阻断促进抗肿瘤免疫。
Nat Commun. 2021 Jul 21;12(1):4445. doi: 10.1038/s41467-021-24767-5.
8
Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.通过调节 Treg-树突状细胞轴靶向治疗冷肿瘤微环境中的头颈鳞癌对放化疗抵抗。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-001955.
9
CXCR6 deficiency impairs cancer vaccine efficacy and CD8 resident memory T-cell recruitment in head and neck and lung tumors.CXCR6 缺陷会损害头颈部和肺部肿瘤的癌症疫苗疗效和 CD8 驻留记忆 T 细胞募集。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001948.
10
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.头颈部鳞状细胞癌患者的新辅助抗 OX40(MEDI6469)治疗可激活和扩增抗原特异性肿瘤浸润 T 细胞。
Nat Commun. 2021 Feb 16;12(1):1047. doi: 10.1038/s41467-021-21383-1.